Inorganic Chemistry
Article
2.2. Synthesis of Ligands. Methyl-2-phenyl-1H-imidazole
(MHpiH) was synthesized using the method reported.27 The reaction
yield was 38%, and details were described in the Supporting
Information.
1-Butyl-2-(4-fluorophenyl)-1H-imidazole (FpiH) was synthesized
using the method reported.28 The reaction yield was 11%. Other
ligands, 1-butyl-2-(4-(trifluoromethyl)phenyl)-1H-imidazole
(CF3piH), 1-butyl-2-(4-(trifluoromethoxy)phenyl)-1H-imidazole
(OCF3piH), 1-butyl-2-(4-methoxyphenyl)-1H-imidazole (OCH3piH),
and 1-butyl-2-phenyl-1H-imidazole (HpiH), were also synthesized
using the same method, and their yields were 35%, 18%, 30%, and
36%, respectively, and details were described in the Supporting
Information.
110 °C. After cooling to ambient temperature, water (100 mL) and
brine (30 mL) were added. The organic layer was extracted three
times with CH2Cl2. The solvent was removed in vacuo, and crude μ-Cl
dimer complex was obtained. A mixture of acetylacetone (250 mg, 2.50
mmol) and potassium carbonate (354 mg, 2.56 mmol) in 25 mL of 2-
ethoxyethanol was added, and this reaction mixture was stirred for 6 h
at 110 °C. After cooling to ambient temperature, water (100 mL) and
brine (30 mL) were added. The organic layer was extracted three
times with CH2Cl2. Brown powder was obtained after removal of the
solvent in vacuo. The product was purified by precipitation (CH2Cl2
and hexane) after the column chromatography (alumina, CH2Cl2), and
the complex was obtained as a pale yellow powder (52 mg, 13%).
1H NMR (CDCl3, 300 MHz, 300 K): δ (ppm) 7.28−7.26 (m, 2H),
6.99 (d, J = 1.4 Hz, 2H), 6.92 (d, J = 1.4 Hz, 2H), 6.74−6.69 (m, 2H),
6.62−6.57 (m, 2H), 6.37−6.35 (m, 2H), 5.15 (s, 1H), 4.46−4.27 (m,
4H), 2.00−1.90 (m, 4H), 1.77 (s, 6H), 1.53−1.41 (m, 4H), 1.00 (t, J =
7.4 Hz, 6H).
2.3. Synthesis of Homoleptic Complexes. The fac-tris[2-(4-
trifluoromethylphenyl)-3-butyl-[1,3]-imidazolynato-C2,N1]iridium(III)
complex (fac-CF3) is given as an example.29
Iridium(III) trisacetylacetonate (763 mg, 1.56 mmol), CF3piH
(2.10 g, 7.83 mmol), and 9 mL glycerol that was deoxygenated by
argon bubbling at 70 °C for 10 min were placed in a 50 mL three-
necked flask. The mixture was stirred and heated up to 230 °C under
nitrogen for 3.5 h. CH2Cl2 (60 mL) was added after cooling down to
ambient temperature. An insoluble yellow precipitate was observed in
the organic layer. AcOEt (40 mL) was added, and the precipitates
were separated by filtration. The organic layer was washed twice with a
mixture of water (100 mL) and sat. aq NaCl (40 mL), and then once
with water, dried with anhydrous sodium sulfate, followed by solvent
evaporation. The yellow powder was reprecipitated twice using
CH2Cl2 and methanol to yield 398 mg. High-performance liquid
chromatography (HPLC) analysis revealed that the reaction mixture
contained equal amounts of the meridional isomer. Therefore, the
powder was well stirred in 100 mL of CH2Cl2, and the residual facial
isomer was obtained as ocher powder by filtration and dried under
vacuum (156 mg, 0.16 mol, yield 10%). An HPLC chromatograph
gave a single peak assigned to the facial isomer.
ESIMS: m/z = 749.2236, theoretical mass = 749.2250, δ = −1.85
ppm.
Anal. Calcd for C31H35F2IrN4O2: C, 51.30; H, 4.86; N, 7.72. Found:
C, 51.42; H, 4.78; N, 7.48.
The iridium(III) bis[2-(4-trifluoromethylphenyl)-3-butyl-[1,3]-imi-
dazolynato-C2,N1]acetylacetonate (CF3acac) was obtained as yellow
powder (yield 63%) using the same method.
1H NMR (CDCl3, 300 MHz, 300 K): δ (ppm) 7.32 (d, J = 7.5 Hz,
2H), 7.04 (d, J = 1.5 Hz, 2H), 7.02 (d, J = 1.5 Hz, 2H), 6.97 (d, J = 7.5
Hz, 2H), 6.46 (s, 2H), 5.19 (s, 1H), 4.58−4.22 (m, 4H), 1.95−1.87
(m, 4H), 1.80 (s, 6H), 1.51−1.39 (m, 4H), 0.98 (t, J = 7.3 Hz, 6H).
ESIMS: m/z = 827.2347, theoretical mass = 827.2366, δ = −2.35
ppm.
Anal. Calcd for C33H35F6IrN4O2: C, 47.99; H, 4.27; N, 6.78. Found:
C, 48.18; H, 4.15; N, 6.91.
The iridium(III) bis[2-(4-trifluoromethoxyphenyl)-3-butyl-[1,3]-
imidazolynato-C2,N1]acetylacetonate (OCF3acac) was obtained as
yellow powder (yield 41%) using the same method.
1H NMR (CD2Cl2, 300 MHz, 300 K): δ (ppm) 7.33 (d, J = 8.5 Hz,
2H), 7.06 (d, J = 1.5 Hz, 2H), 6.97 (d, J = 1.5 Hz, 2H), 6.68 (dd, J =
8.5 and 1.3 Hz, 2H), 6.07 (d, J = 1.3 Hz, 2H), 5.22 (s, 1H), 4.49−4.26
(m, 4H), 1.98−1.88 (m, 4H), 1.79 (s, 6H), 1.51−1.41 (m, 4H), 0.99
(t, J = 7.4 Hz, 6H).
ESIMS: m/z = 859.2247, theoretical mass = 859.2265, δ = −2.07
ppm.
Anal. Calcd for C33H35F6IrN4O4: C, 46.20; H, 4.11; N, 6.53. Found:
C, 46.17; H, 4.11; N, 6.52.
1H NMR (CD2Cl2, 300 MHz, 300 K): δ (ppm) 7.47 (d, J = 8.2 Hz,
3H), 7.10 (d, J = 8.2 Hz, 3H), 7.06 (s, 3H), 6.90 (d, J = 1.4 Hz, 3H),
6.37 (d, J = 1.4 Hz, 3H), 4.44−4.23 (m, 6H), 1.93−1.83 (m, 6H),
1.48−1.36 (m, 6H), 0.96 (t, J = 7.4 Hz, 9H).
ESI-MS: m/z = 995.3013, theoretical mass = 995.3029, δ = −1.60
ppm.
Anal. Calcd for C42H42F9IrN6: C, 50.75; H, 4.26; N, 8.45. Found: C,
50.63; H, 4.26; N, 8.29.
The fac-tris[2-(4-trifluoromethoxyphenyl)-3-butyl-[1,3]-
imidazolynato-C2,N1]iridium(III) complex (fac-OCF3) was obtained
as an ocher powder (yield 23%) using the same method.
1H NMR (CD2Cl2, 300 MHz, 300 K): δ (ppm) 7.40 (d, J = 8.5 Hz,
3H), 6.86 (d, J = 1.4 Hz, 3H), 6.72 (d, J = 8.5 Hz, 3H), 6.67 (s, 3H),
6.35 (d, J = 1.4 Hz, 3H), 4.37−4.19 (m, 6H), 1.93−1.80 (m, 6H),
1.49−1.37 (m, 6H), 0.97 (t, J = 7.3 Hz, 9H).
The iridium(III) bis[2-(4-methoxyphenyl)-3-butyl-[1,3]-imidazoly-
nato-C2,N1]acetylacetonate (OCH3acac) was obtained as pale yellow
powder (yield 20%) using the same method.
1H NMR (CDCl3, 300 MHz, 300 K): δ (ppm) 7.20 (d, J = 8.5 Hz,
2H), 6.94 (d, J = 1.4 Hz, 2H), 6.84 (d, J = 1.4 Hz, 2H), 6.30 (dd, J =
8.5 and 2.6 Hz, 2H), 5.90 (d, J = 2.6 Hz, 2H), 5.14 (s, 1H), 4.40−4.18
(m, 4H), 3.55 (s, 6H), 1.96−1.86 (m, 4H), 1.77 (s, 6H), 1.52−1.39
(m, 4H), 0.98 (t, J = 7.4 Hz, 6H).
ESI-MS: m/z = 1043.2870, theoretical mass = 1043.2877, δ = −0.65
ppm.
Anal. Calcd for C42H42F9IrN6O3: C, 48.41; H, 4.06; N, 8.07. Found:
C, 48.23; H, 3.96; N, 7.82.
The fac-tris[2-(4-fluorophenyl)-3-butyl-[1,3]imidazolynato-C2,N1]-
iridium(III) complex (fac-F) was obtained as an ocher powder
(yield 1%) using the same method.
ESIMS: m/z = 750.2732, theoretical mass = 750.2752, δ = −2.54
ppm.
Anal. Calcd for C33H41IrN4O4: C, 52.85; H, 5.51; N, 7.47. Found:
C, 52.51; H, 5.45; N, 7.34.
1H NMR (CD2Cl2, 300 MHz, 300 K): δ (ppm) 7.36 (dd, J = 8.2
Hz, JFH = 5.6 Hz, 3H), 6.82 (d, J = 1.3 Hz, 3H), 6.60−6.51 (m, 6H),
6.30 (d, J = 1.3 Hz, 3H), 4.37−4.17 (m, 6H), 1.93−1.82 (m, 6H),
1.49−1.37 (m, 6H), 0.97 (t, J = 7.3 Hz, 9H).
The iridium(III) bis[2-phenyl-3-butyl-[1,3]-imidazolynato-C2,N1]-
acetylacetonate (Hacac) was obtained as yellow powder (yield 18%)
using the same method.
ESI-MS: m/z = 845.3115, theoretical mass = 845.3125, δ = −1.17
ppm.
1H NMR (CDCl3, 300 MHz, 300 K): δ (ppm) 7.27 (d, J = 7.5 Hz,
2H), 6.99 (d, J = 1.4 Hz, 1H), 6.92 (d, J = 1.4 Hz, 1H), 6.72 (dt, J =
7.5 and 1.2 Hz, 2H), 6.60 (dt, J = 7.5 and 1.3 Hz, 2H), 6.36 (dd, J =
7.5 and 1.2 Hz, 2H), 5.15 (s, 1H), 4.46−4.27 (m, 4H), 2.00−1.90 (m,
4H), 1.77 (s, 6H), 1.53−1.41 (m, 4H), 1.00 (t, J = 7.4 Hz, 6H).
ESIMS: m/z = 690.2511, theoretical mass = 690.2540, δ = −4.24
ppm.
Anal. Calcd for C39H42F3IrN6: C, 55.50; H, 5.02; N, 9.96. Found: C,
55.21; H, 4.95; N, 9.71.
2.4. Syntheses15,30 of Diketonate Complexes. Iridium(III)
bis[2-(4-fluorophenyl)-3-butyl-[1,3]-imidazolynato-C2,N1]-
acetylacetonate (Facac) is given as an example.
A mixture of iridium(III) chloride n-hydrate (201 mg, 0.54 mmol),
FpiH (293 mg, 1.34 mmol), 2-ethoxyethanol (30 mL), and H2O (10
mL) were set in the flask, purged with nitrogen, and stirred for 6 h at
Anal. Calcd for C31H37IrN4O2: C, 53.97; H, 5.41; N, 8.12. Found:
C, 53.72; H, 5.37; N, 7.85.
C
dx.doi.org/10.1021/ic400950u | Inorg. Chem. XXXX, XXX, XXX−XXX